How Informative Are Parent Reports of Attention-Deficit/Hyperactivity Disorder Symptoms for Assessing Outcome in Clinical Trials of Long-Acting Treatments? A Pooled Analysis of Parents and Teachers Reports



* Pediatric Psychopharmacology Research, Massachusetts General Hospital, Boston, Massachusetts
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
Objective. The validity of parent reports of childrens attention-deficit/hyperactivity disorder (ADHD) symptoms has been questioned, especially in clinical trials. Some advocate the exclusive use of teacher reports, maintaining that parent reports are not sensitive to changes in ADHD symptoms. This study compares the ability of parent and teacher reports to document change during clinical trials of long-acting treatments.
Methods. We conducted a literature search of Medline to identify any published clinical trials in pediatric ADHD that met the following criteria: 1) used a randomized design, 2) examined the efficacy of long-acting agents or standard formulations using 3-times-a-day dosing, and 3) used both parent and teacher reports of the same measure of ADHD symptoms as a study outcome. For each measurement of ADHD symptoms, we calculated effect sizes for parent and teacher reports.
Results. Three large, randomized, controlled clinical trials were identified (N = 1445 subjects). For every outcome for which teacher reports documented significant improvement, parent reports did also. Pooled analysis revealed a larger effect captured by the parent report relative to the teacher report.
Conclusion. Results suggest that parent reports are at least as sensitive to detecting change in ADHD symptoms as teacher reports in clinical trials that assess the efficacy of long-acting agents. These results suggest that parent reports are informative for detecting change during treatment of children with ADHD.
Key Words: ADHD clinical trials pooled analysis long-acting treatments parent reports
Abbreviations: ADHD, attention-deficit/hyperactivity disorder MTA, Multimodal Treatment of ADHD tid, 3 times a day IR, immediate-release MPH, methylphenidate OROS, ostomotic-release oral system SNAP, Swanson, Nolan, and Pelham questionnaire
Received for publication Jun 14, 2002; Accepted Jul 7, 2003.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
A. M. Re and C. Cornoldi Two New Rating Scales for Assessment of ADHD Symptoms in Italian Preschool Children: A Comparison Between Parent and Teacher Ratings J Atten Disord, May 1, 2009; 12(6): 532 - 539. [Abstract] [PDF] |
||||
![]() |
J. H. Newcorn, C. J. Kratochvil, A. J. Allen, C. D. Casat, D. D. Ruff, R. J. Moore, D. Michelson, and Atomoxetine/Methylphenidate Comparative Study Grou Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response Am J Psychiatry, June 1, 2008; 165(6): 721 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Perwien, C. J. Kratochvil, D. Faries, B. Vaughan, J. Busner, K. E. Saylor, C. M. Buermeyer, S. Kaplan, and R. Swindle Emotional Expression in Children Treated With ADHD Medication: Development of a New Measure J Atten Disord, March 1, 2008; 11(5): 568 - 579. [Abstract] [PDF] |
||||
![]() |
B. N. Bohnstedt, W. G. Kronenberger, D. W. Dunn, A. L. Giauque, E. A. Wood, M. E. Rembusch, and D. Lafata Investigator Ratings of ADHD Symptoms During a Randomized, Placebo-Controlled Trial of Atomoxetine: A Comparison of Parents and Teachers as Informants J Atten Disord, May 1, 2005; 8(4): 153 - 159. [Abstract] [PDF] |
||||
![]() |
C. Kemp Parents accurately assess ADHD treatment AAP News, August 1, 2004; 25(2): 54 - 54. [Full Text] [PDF] |
||||







